NewEdge Advisors’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $290 | Hold |
100
| – | – | ﹤0.01% | 3853 |
|
|
2025
Q1 | $72 | Hold |
100
| – | – | ﹤0.01% | 3838 |
|
|
2024
Q4 | $103 | Hold |
100
| – | – | ﹤0.01% | 3778 |
|
|
2024
Q3 | $134 | Hold |
100
| – | – | ﹤0.01% | 3706 |
|
|
2024
Q2 | $130 | Hold |
100
| – | – | ﹤0.01% | 3677 |
|
|
2024
Q1 | $172 | Hold |
100
| – | – | ﹤0.01% | 3680 |
|
|
2023
Q4 | $147 | Hold |
100
| – | – | ﹤0.01% | 3620 |
|
|
2023
Q3 | $121 | Hold |
100
| – | – | ﹤0.01% | 3356 |
|
|
2023
Q2 | $145 | Hold |
100
| – | – | ﹤0.01% | 3399 |
|
|
2023
Q1 | $145 | Hold |
100
| – | – | ﹤0.01% | 3325 |
|
|
2022
Q4 | $0 | Buy |
+100
| New | – | ﹤0.01% | 4201 |
|